3 recruiting, 2 completed, 2 not yet recruiting, 2 unknown. 4 Phase 2, 3 Phase 1, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Not yet recruiting 2, Completed 1, Recruiting 1 |
| Phase 1 | 3 | Completed 1, Not yet recruiting 1, Recruiting 1 |
| Not applicable | 1 | Unknown 1 |
Follow Gynecological Malignancies: new trials by email Literature Review of Gynecological Malignancies trials Research Report on Gynecological Malignancies
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of BL-M09D1 in Patients With Locally Advanced or Metastatic Gynecological Malignancies and Other Solid Tumors BL-M09D1 - Gynecological Malignancies, Solid Tumors | Phase 2 | Not yet recruiting | Sichuan Baili Pharmaceutical Co., Ltd. | 126 | 2026-08-01 | 2026-08-26 |
| 9MW2821 Combined With Other Antitumor Drugs in Patients With Advanced Gynecological Tumors 9MW2821+other anticancer therapy - Gynecological Malignancies | Phase 1 / Phase 2 | Not yet recruiting | Mabwell (Shanghai) Bioscience Co., Ltd. | 260 | 2025-04-15 | 2025-04-15 |
| A Study of BL-M07D1 in Patients With Recurrent or Metastatic Gynecologic Malignancies BL-M07D1 - Gynecological Malignancies | Phase 1 / Phase 2 | Recruiting | Sichuan Baili Pharmaceutical Co., Ltd. | 158 | 2024-02-29 | 2026-10-23 |
| An Observational Study of Menopausal Symptom in Patients With Gynecological Malignancy After Oophorectomy No intervention - Gynecological Malignancies, Menopausal Symptoms | Recruiting | Anhui Provincial Hospital | 490 | 2023-12-01 | 2024-03-07 | |
| Immunotherapy-related CRP Kinetics in Metastatic Gynecological Malignancies Gynecological Malignancies, Cervical Cancer | Recruiting | University Hospital Tuebingen | 120 | 2023-09-11 | 2026-02-10 | |
| A Multicenter Prospective Post-registration Study of Empegfilgrastim to Evaluate Safety and Efficacy in Special Cancer Populations Empegfilgrastim - Solid Tumor, High-Risk Cancer | Unknown | Moscow Clinical Scientific Center | 285 | 2020-04-28 | 2021-06-02 | |
| The Development of an In-vitro System to Identify Gynecologic Cancer Cells During Surgical Procedures Mid-Infrared Spectroscopy with ATR - Gynecological Malignancies | Not applicable | Unknown | Hillel Yaffe Medical Center | 60 | 2016-04-01 | 2016-03-24 |
| AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CR A1: AMG 386 10 mg/kg + Liposomal doxorubicin, A3: AMG 386 15mg/kg + Liposomal doxorubicin, B1: AMG 386 10 mg/kg + Topotecan - Cancer, Carcinoma | Phase 1 | Completed | Amgen | 103 | 2009-01-01 | 2015-09-29 |
| Treatment for Patients With Gynecological Malignancies Who Suffer From Anemia Due to Chemotherapy darbepoetin alfa, recombinant human erythropoietin (rHuEPO) - Gynecological Malignancies, Genital Neoplasms, Female | Phase 2 | Completed | Amgen | 2002-10-01 | 2007-12-24 |
Ovarian Neoplasms (3) · Anemia (1) · Bone Diseases, Metabolic (1) · Breast Neoplasms (1) · Carcinoma (1) · Endometrial Neoplasms (1) · Fallopian Tube Neoplasms (1) · Gastrointestinal Neoplasms (1) · Genital Neoplasms, Female (1) · Neoplasm Metastasis (1) · Neoplasms (1) · Uterine Cervical Neoplasms (1) · Uterine Neoplasms (1) · Vulvar Neoplasms (1)
Neoplasms by Site (4) · Adnexal Diseases (3) · Endocrine Gland Neoplasms (3) · Endocrine System Diseases (3) · Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Genital Diseases (3) · Genital Diseases, Female (3) · Gonadal Disorders (3) · Neoplasms (3) · Ovarian Diseases (3) · Urogenital Diseases (3) · Urogenital Neoplasms (3) · Genital Neoplasms, Female (2) · Uterine Diseases (2)
Darbepoetin alfa (1) · Topotecan (1) · liposomal doxorubicin (1) · trebananib (1)
Amgen (2) · Sichuan Baili Pharmaceutical Co., Ltd. (2) · Anhui Provincial Hospital (1) · Hillel Yaffe Medical Center (1) · Mabwell (Shanghai) Bioscience Co., Ltd. (1) · Moscow Clinical Scientific Center (1) · University Hospital Tuebingen (1)
China (4) · Australia (1) · Belgium (1) · Germany (1) · Israel (1) · Russia (1) · United States (1)
Alexey Tryakin, MD, PhD, professor (1) · Dominik Dannehl, Dr. (1) · Hanmei Lou, Professor (1) · Ilan Bruchim, MD (1) · Inna Ganshina, MD, PhD (1) · Lingying Wu, PHD (1) · Lyudmila Zhukova, MD, PhD, professor (1) · Mikhail Fedyanin, MD, PhD, professor (1) · Svetlana Khokhlova, MD, PhD (1) · Ying Zhou, MD (1)